Skip to main content

Table 1 Demographic and clinical characteristics of MS patients treated with MX

From: Cardiovascular comorbidity in multiple sclerosis patients treated with Mitoxantrone therapy: a cohort study

Variable

N

Gender (W/M)

264 (158/106)

Mean age at onset (years +/- SD)

48 (10.3)

Disease course

 

 RR

65 (41 D/24 U)

 SP

132 (82 D/50 U)

 PP

38 (19 D/19 U)

 PR

29 (16 D/13 U)

Mean disease duration (years, range)

11,3 (1 – 38)

Mean Follow-up (years +/- SD)

8 (3)

Mean number of MTX (range)

7,5 (1 – 21)

Mean cumulative dose/m2 (range)

70,8 (1 – 139)